ICLR Icon Plc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ICLR

Price (delayed)

$165.76

Market cap

$12.7B

P/E Ratio

29.29

Dividend/share

N/A

EPS

$5.66

Enterprise value

$15.44B

?
Relative Growth: Rel. Growth: 23
Relative Strength: Rel. Strength: 70
Relative Valuation: Rel. Valuation: 54
Relative Profitability: Rel. Profitability: 44

icon is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. we specialise in the strategic development, management and analysis of programmes that support ...

Highlights
The price to earnings (P/E) is 36% lower than the 5-year quarterly average of 45.6
The EPS has surged by 94% since the previous quarter but it has declined by 42% year-on-year
The net income has soared by 92% from the previous quarter but it has contracted by 45% YoY
Icon's gross margin has decreased by 14% YoY and by 4.2% QoQ
ICLR's gross profit is down by 14% year-on-year and by 4.6% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.iconplc.com/
Peers: CRL SCYX

Key stats

What are the main financial stats of ICLR

ICLR stock price

How has the Icon stock price performed over time
Intraday
-2.68%
1 week
-2.49%
1 month
4.8%
1 year
-15%
YTD
-9.03%
QTD
-4.58%

Financial performance

How have Icon's revenue and profit performed over time
Revenue
$8.21B
Gross profit
$2.07B
Operating income
$677.37M
Net income
$439.27M
Gross margin
25.3%
Net margin
5.4%
The net margin has soared by 93% from the previous quarter but it has contracted by 44% YoY
The net income has soared by 92% from the previous quarter but it has contracted by 45% YoY
The company's operating margin has surged by 54% QoQ but it fell by 36% YoY
The operating income has soared by 53% from the previous quarter but it has contracted by 37% YoY

Price vs fundamentals

How does ICLR's price correlate with its fundamentals

Growth

What is Icon's growth rate over time

Valuation

What is Icon stock price valuation
ICLR P/E details
P/E
29.29
P/B
1.36
P/S
1.55
EV/EBIT
22.56
EV/EBITDA
14.54
EV/Sales
1.88
The EPS has surged by 94% since the previous quarter but it has declined by 42% year-on-year
The price to earnings (P/E) is 36% lower than the 5-year quarterly average of 45.6
The price to book (P/B) is 32% lower than the 5-year quarterly average of 2.0 but 4.6% higher than the last 4 quarters average of 1.3
Icon's equity has decreased by 2.1% YoY
ICLR's P/S is 38% below its 5-year quarterly average of 2.5 but 3.3% above its last 4 quarters average of 1.5

Efficiency

How efficient is Icon business performance
ICLR's return on equity has surged by 96% since the previous quarter but it is down by 44% year-on-year
The company's return on assets has surged by 93% QoQ but it fell by 43% YoY
The company's return on invested capital has surged by 57% QoQ but it fell by 31% YoY
The return on sales has surged by 51% since the previous quarter but it has declined by 37% year-on-year

Dividends

What is ICLR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ICLR.

Financial health

How did Icon financials performed over time
The total assets is 133% more than the total liabilities
Icon's current ratio has decreased by 10% YoY but it has increased by 3.6% from the previous quarter
Icon's quick ratio has decreased by 10% YoY but it has increased by 2.8% QoQ
The debt is 62% less than the equity
The debt to equity has grown by 2.7% year-on-year
Icon's equity has decreased by 2.1% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.